Please Enable Cookies

www.cablinginstall.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation process is complete.

Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S ADR (NY: NVO )

132.92 +0.51 (+0.39%)
Official Closing Price Updated: 7:00 PM EDT, May 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,920,659
Open 132.18
Bid (Size) 132.50 (1)
Ask (Size) 133.00 (13)
Prev. Close 132.41
Today's Range 131.30 - 133.00
52wk Range 75.56 - 138.28
Shares Outstanding N/A
Dividend Yield 1.33%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity
Via Benzinga
2 Top Pharma Stocks That Just Keep Getting Better and Better
Both of these businesses are finding traction in a pair of major markets. 
Via The Motley Fool

Performance

YTD
+30.17%
+30.17%
1 Month
+7.28%
+7.28%
3 Month
+10.78%
+10.78%
6 Month
+33.99%
+33.99%
1 Year
+56.90%
+56.90%

More News

Read More
Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
Via Benzinga
Novo Nordisk's Hemophilia Candidate Can Prevent Bleeding Episodes Effectively, Regardless Of Dosing Frequency
Via Benzinga
How Viking Therapeutics Stock Could 30x
Via The Motley Fool
The Must-Watch List: 3 Stocks to Snap Up as Soon as They Hit Bargain Territory
Via InvestorPlace
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Via The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
Via The Motley Fool
7 Stocks That Ordinary Investors Can’t Get Enough Of Right Now
Via InvestorPlace
Can Weight Loss Companies Fuel Gains In Your Stock Portfolio?
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025
Via InvestorPlace
3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy
Via The Motley Fool
Biotech Breakthroughs: 7 Stocks Driving the Next Wave in Healthcare
Via InvestorPlace
Investors should take note of NYSE:NVO, a growth stock that remains attractively priced.
Via Chartmill
Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
Via MarketBeat
'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem
Via Benzinga
Eli Lilly Raised Its Outlook. Is the Stock a Buy Now?
Via The Motley Fool
Why Amgen Stock Zoomed Nearly 12% Higher Today
Via The Motley Fool
3 Under-The-Radar Stocks That Could Be Worth Over $1 Trillion by 2030
Via InvestorPlace
Stock Market Rallies On Fed, Jobs Report, Apple: Weekly Review
Via Investor's Business Daily
Topics Economy
Exposures Interest Rates
Wage Growth Slows – Stock Market Celebrates, Five Real Reasons Apple Is Running Up
Via Benzinga
AMGN Stock Alert: Is Amgen the Next Hot Weight-Loss Drug Company?
Via InvestorPlace
The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy?
Via InvestorPlace
This Is a Huge Sigh of Relief for Novo Nordisk Investors
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.